autoimmune disease

Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
Yahoo/Benzinga
Tue, 11/19/24 - 07:09 pm
Bristol Myers Squibb
ACR
clinical trials
autoimmune disease
More turbulence at Aurinia as autoimmune drugmaker lays off 45% of workforce
Fierce Pharma
Thu, 11/7/24 - 11:52 pm
Aurinia Pharmaceuticals
autoimmune disease
layoffs
restructuringhttps://www.fiercepharma.com/pharma/more-turbulence-aurinia-autoimmune-drugmaker-lays-45-workforce
Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders
PR Newswire
Thu, 11/7/24 - 11:23 am
Aditum Bio
Leads Biolabs
Oblenio Bio
Joe Jimenez
autoimmune disease
T-cell engager
Sana to lay off staff, deepen autoimmune focus in latest retrenchment
BioPharma Dive
Tue, 11/5/24 - 09:58 am
Sana Biotechnology
layoffs
autoimmune disease
Sanofi Offloads Rare Autoimmune Drug to Recordati in Potential $1B Deal
BioSpace
Fri, 10/4/24 - 09:17 am
Sanofi
Recordati
autoimmune disease
cold agglutinin disease
Candid, with $370M, sets out to prove bispecifics’ worth in autoimmune disease
BioPharma Dive
Mon, 09/9/24 - 10:56 am
Candid Therapeutics
T-cell engager
RayzeBio
autoimmune disease
funding
Merck bets $700M on an antibody drug’s potential in immune diseases
BioPharma Dive
Fri, 08/9/24 - 11:57 am
Merck
autoimmune disease
Curon Biopharmaceutical
China
bispecific antibodies
Cue Biopharma downsizes to focus on autoimmune pipeline
Clinical Trials Arena
Fri, 07/26/24 - 11:09 am
Cue Biopharma
autoimmune disease
layoffs
J&J vets burst into biotech with $165M Third Arc series A
Fierce Biotech
Tue, 07/23/24 - 11:22 am
JNJ
Third Arc Bio
funding
solid tumors
autoimmune disease
Artiva prices $167M IPO, riding optimism for autoimmune cell therapy
BioPharma Dive
Fri, 07/19/24 - 11:43 am
Artiva
IPOs
autoimmune disease
Kyverna follows oncology’s CAR-T cell playbook for an ultra-rare autoimmune disorder
Pharma Voice
Fri, 07/19/24 - 11:39 am
Kyverna Therapeutics
CAR-T
stiff person syndrome
autoimmune disease
Artiva sets out $135M IPO plans to push NK cell therapy through trials
Fierce Biotech
Mon, 07/15/24 - 09:58 am
Artiva
IPO
autoimmune disease
natural killer cell therapies
SciRhom pulls in $70M for a new type of immune disease drug
BioPharma Dive
Tue, 07/9/24 - 09:12 pm
SciRhom
autoimmune disease
funding
Zenas adds $200M series C to reach a bucket of key readouts for its lead monoclonal antibody
Fierce Biotech
Tue, 05/7/24 - 10:58 am
Zenas BioPharma
funding
monoclonal antibodies
obexelimab
autoimmune disease
Repertoire pivot pays dividends with Bristol Myers deal
BioPharma Dive
Mon, 04/29/24 - 11:28 am
Bristol Myers Squibb
Repertoire Immune Medicines
vaccines
autoimmune disease
Colorado could cap payments for Amgen’s Enbrel
Stat
Thu, 02/22/24 - 11:47 am
Colorado
Amgen
autoimmune disease
Enbrel
reimbursement
Small study adds to growing hope CAR-T cell therapy could revolutionize autoimmune disease treatment
Stat
Wed, 02/21/24 - 10:47 pm
CAR-T
New England Journal of Medicine
autoimmune disease
J&J's immune disorder drug succeeds in mid and late-stage studies
Reuters
Mon, 02/5/24 - 10:14 am
JNJ
autoimmune disease
clinical trials
nipocalimab
myasthenia gravis
Sjögren’s syndrome
Kyverna sets IPO range, eyeing $180M haul to fund broad autoimmune CAR-T clinical trial program
Fierce Biotech
Thu, 02/1/24 - 11:19 am
Kyverna Therapeutics
IPOs
cell therapy
autoimmune disease
Cour gets $105M, pharma help to ‘reprogram’ autoimmune disease
BioPharma Dive
Tue, 01/30/24 - 11:10 am
Cour Pharmaceuticals
funding
autoimmune disease
Roche
Pfizer
Bristol Myers Squibb
nanoparticles

Pages